These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14658980)

  • 1. Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.
    Hofer A; Fleischhacker WW; Hummer M
    J Clin Psychiatry; 2003 Oct; 64(10):1267-8. PubMed ID: 14658980
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychotic symptoms associated with topiramate: cognitive side effects or worsening of psychosis?
    Duggal HS
    J Clin Psychiatry; 2004 Aug; 65(8):1145; author reply 1145--6. PubMed ID: 15323603
    [No Abstract]   [Full Text] [Related]  

  • 3. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate for clozapine-induced seizures.
    Navarro V; Pons A; Romero A; Bernardo M
    Am J Psychiatry; 2001 Jun; 158(6):968-9. PubMed ID: 11384919
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate and other anticonvulsants for psychiatric disorders.
    Med Lett Drugs Ther; 2000 Dec; 42(1094):114-5. PubMed ID: 11114842
    [No Abstract]   [Full Text] [Related]  

  • 8. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar Rates of Autism With Lamotrigine, Topiramate, and No Treatment; Rate With Valproate Is Higher.
    Speer L
    Am Fam Physician; 2024 Jul; 110(1):90-91. PubMed ID: 39028792
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Solomon GE
    Neurology; 2000 Aug; 55(4):606. PubMed ID: 10953214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.
    Levisohn PM; Holland KD
    Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
    Afshari D; Rafizadeh S; Rezaei M
    Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
    Chengappa KN; Chalasani L; Brar JS; Parepally H; Houck P; Levine J
    Clin Ther; 2002 Oct; 24(10):1576-84. PubMed ID: 12462287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
    Hahn MK; Remington G; Bois D; Cohn T
    J Clin Psychopharmacol; 2010 Dec; 30(6):706-10. PubMed ID: 21105286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate related obsessive-compulsive disorder.
    Ozkara C; Ozmen M; Erdogan A; Yalug I
    Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.